Nichols, Mark <br/><br/>
New directions for drug-resistant breast cancer: the CDK4/6 inhibitors.  [electronic resource] 

 -  Future medicinal chemistry  Aug 2015 
 - 1473-81 p.  digital 
<br/><br/> Publication Type: Journal Article; Research Support, N.I.H., Extramural; Review 
<br/><br/><label>ISSN: </label>1756-8927 
<br/><br/><label>Standard No.: </label>10.4155/fmc.15.86  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Animals<br/>Antineoplastic Agents--pharmacology<br/>Aromatase Inhibitors--pharmacology<br/>Breast--drug effects<br/>Breast Neoplasms--drug therapy<br/>Cell Cycle--drug effects<br/>Cyclin-Dependent Kinase 4--antagonists & inhibitors<br/>Cyclin-Dependent Kinase 6--antagonists & inhibitors<br/>Drug Discovery<br/>Drug Resistance, Neoplasm<br/>Female<br/>Humans<br/>Molecular Targeted Therapy<br/>Protein Kinase Inhibitors--pharmacology<br/>Selective Estrogen Receptor Modulators--pharmacology